"I had one of the collagen injectables, my cheek feels lumpy, and dissolving it didn't fully clear it." I hear a version of this almost every week. The hard part is often not the lump itself. It is that we haven't yet pinned down which material caused it.
First, work out which "collagen needle" you actually had
The names in this category are a mess, especially once they cross languages. Several different materials share similar marketing nicknames, and whether your lump can be dissolved depends entirely on which one is under your skin. So step one is translating the name back into an ingredient.
← Swipe to see more →
| Marketing name | Actual product | Main ingredient | Does hyaluronidase work? |
|---|---|---|---|
| Sculptra, "collagen needle" | Sculptra | PLLA (poly-L-lactic acid) | No |
| Juvelook, "new collagen needle" | Juvelook (volumizing version = Lenisna) | PDLLA + hyaluronic acid composite | Only on the HA half |
| AestheFill, "elf needle" | AestheFill | PDLLA powder (no HA) | No |
| Ellansé, "girl needle" | Ellansé | PCL (polycaprolactone) | No |
Notice the pattern. The only one of these where hyaluronidase does anything at all is Juvelook, and even then only partway. The rest are all materials that stimulate your own collagen; there is no HA for the enzyme to act on. So when someone tells you "just dissolve it," the honest first question is whether they confirmed what you were injected with.
This article is about Juvelook specifically. It is a Korean composite (made by VAIM) that suspends PDLLA (poly-D,L-lactic acid) microspheres in non-cross-linked hyaluronic acid (HA). The small-particle base version is marketed for skin quality and often placed superficially, "skin-booster" style; the larger-particle, higher-concentration version is sold as Lenisna in Japan for volume. AestheFill is also PDLLA, but it is a pure powder with no HA, and its lumps behave differently, which I cover in the AestheFill nodule treatment ladder.
Why hyaluronidase only dissolves half: Juvelook is only half-reversible
This is the part that most people misunderstand, and it is the whole point of the article.
Pure hyaluronic acid is reversible. Hyaluronidase (an enzyme that breaks down HA) can dissolve it. But Juvelook is not pure HA. It is a composite. When hyaluronidase goes in, the only thing it can take apart is the HA that acts as the carrier. The part that actually becomes a lasting lump, the PDLLA microspheres and the collagen your body builds around them, is untouched.
Key point: Juvelook is half-reversible. Dissolve the HA half and the lump shrinks a little, so it looks like it worked. Then the PDLLA keeps stimulating collagen and the firmness often comes back. That is not an under-dose of enzyme. It is the enzyme working on the wrong target.
This logic isn't unique to Juvelook. HArmonyCa is also a composite, half HA and half insoluble CaHA microspheres, and it behaves the same way: you think it will dissolve, and it only half does. I go into that in managing HArmonyCa nodules. The shared lesson is simple. With any composite, "it contains HA" does not mean "the whole thing dissolves."
← Swipe to see more →
| Pure HA lump | Juvelook (PDLLA + HA) lump | |
|---|---|---|
| What it is | HA gel | PDLLA microspheres + your own collagen (HA is just the carrier) |
| Response to hyaluronidase | Dissolves | Only the HA half goes; particles and collagen stay |
| Typical history | Dissolve and it's gone | Shrinks, then returns weeks later |
| Main treatment path | Hyaluronidase | Triage by nodule type; ultrasound-guided physical extraction for the stubborn ones |
When lumps appear: a timeline
When a lump showed up is a real clue to what it is, because Juvelook nodules are not all the same thing.
- First few days: usually injection swelling and bruising. It settles on its own and is not a nodule.
- Around three weeks: the literature has documented firm, painless nodules appearing about three weeks after PDLLA in the tear trough (the Seo 2025 case was Juvelook specifically). These non-inflammatory lumps are usually tied to uneven distribution, too-superficial placement, or over-concentration.
- Three months to several years: this leans toward delayed hypersensitivity. The classic story is a spot that was fine, then suddenly turns red and angry.
- Six months to two years: the classic window for a true granuloma (a chronic immune reaction that walls off foreign material into a firm nodule). But do not treat that as a safe period. A granuloma has been reported as early as four months.
In other words, a lump that shows up more than a year after your injection can absolutely be related to it. More time passing does not mean you are in the clear.
The "skin-booster" superficial technique is itself a risk
Juvelook is heavily marketed as a "water-light" skin treatment, placed in fine droplets over a wide area in the superficial dermis. The very thing that sells it, broad coverage and skin-quality improvement, is also what makes it prone to nodules.
These materials were designed to sit at a certain depth, adequately diluted. Placed too shallow and too dense, the particles stay in the superficial dermis, and your body wraps collagen and fibrous tissue around each droplet. The result is not one big lump but a whole field of palpable grittiness. Why these "booster-style" nodules resist dissolving and what they look like on ultrasound is covered in detail in when collagen stimulators are used as skin boosters. Juvelook simply adds the HA layer on top, which makes the "it only dissolved halfway" confusion more obvious.
Four kinds of nodule, four directions
There is no single move for a lump. In practice, treating PDLLA nodules starts by working out which type you have, because the direction changes completely. The published guidance (Magacho-Vieira 2025) lays this out as a diagnostic flowchart.
- Non-inflammatory nodule: not red, not painful, just firm. Start with massage and needle subcision under ultrasound guidance; the literature also describes energy devices, since PDLLA is structurally softer than PLLA and responds reasonably to radiofrequency. This type does not need antibiotics or steroid.
- Infectious: red, swollen, warm, tender, often within days to weeks. This is antibiotic-first, with drainage if needed, not a steroid situation.
- Delayed hypersensitivity / granuloma: recurring "angry" red bumps. This is where intralesional steroid (triamcinolone, an anti-inflammatory injected into the lesion) has a role; add antibiotics if biofilm (a bacterial film on the filler surface) is suspected. There is even a reported case where a PDLLA granuloma responded better to triamcinolone than to collagenase.
- Stubborn, disfiguring, unresponsive to medication: this is when removing the foreign material directly becomes reasonable.
One thing to be clear about: the reason hyaluronidase only half-works on Juvelook is that it acts on HA and nothing else; it has no target on the PDLLA particles or the collagen. By the same logic, this clinic does not offer collagenase as an injectable service; we only note it at the level of the literature. For particles-plus-fibrosis that are already established, my approach is to see the position clearly on ultrasound and then use the single-pinhole physical extraction that our filler revision clinic has developed over the years, rather than repeatedly injecting to suppress symptoms.
When to remove, and when to leave it alone
Before we talk about removal, I want to pump the brakes.
Not every nodule should be treated. A small, symptom-free lump that isn't red, isn't painful, and isn't visible usually does not need chasing with more injections or surgery. Overtreatment is its own kind of harm. It buys you new depressions, more fibrosis, and cost and discomfort for a problem you couldn't see. The published guideline makes the same point directly: for minor issues, think hard about whether any intervention is truly warranted.
So when would I push toward active treatment? Inflammation, signs of infection, steady growth, or a lump that is now visibly changing your face and keeping you from going out. When that is the case, the order is fixed. First use ultrasound to see which layer it sits in, how big it is, and its relationship to vessels and nerves. Then decide which half to dissolve and which part to remove. Seeing before acting matters a lot with a half-soluble composite like Juvelook, because working blind, it is easy to clear only the dissolvable half and leave the real problem behind.
Key point: With a Juvelook lump, sequence matters more than speed. Identify the material, then the nodule type, then locate it on ultrasound, and only then decide whether to remove it. Skipping identification and going straight to dissolving usually just replays the "only half gone" problem.
Frequently asked questions
I dissolved it and it only shrank a little before coming back. Is that a dosing problem?
Usually no; it is a material problem. Juvelook is a PDLLA-plus-HA composite, and hyaluronidase can only break down the HA half. The PDLLA microspheres and the collagen they stimulate have nothing for the enzyme to act on. So "shrinks and returns" is characteristic of this material, not a sign the dose was too low. Adding more hyaluronidase does not help the core that's left, and it can keep irritating the surrounding tissue.
Are Juvelook, "new collagen needle," Sculptra, and AestheFill the same thing?
No. Sculptra (PLLA) is the original "collagen needle." Juvelook (PDLLA + HA) is the newer product borrowing that name. AestheFill (PDLLA powder, no HA) is different again. Similar names, different ingredients, different handling of a lump. Confirming which one you actually had is where every decision starts.
Will a Juvelook lump go away on its own?
It depends on the type and the timing. Day-one swelling settles. A non-inflammatory nodule at three weeks may soften over time, or may not. The hypersensitivity or granuloma type that appears months later usually does not resolve on its own, because the immune reaction is ongoing. So rather than wait, it is better to work out which type you have.
Do I have to have it surgically removed?
Not necessarily. Removal is rarely the first step. Non-inflammatory lumps get subcision and observation first; infected ones get medication first. The ones that actually reach physical extraction are those that are stubborn, unresponsive to medication, or disfiguring, and even then it is done through a single pinhole under ultrasound guidance, not open surgery. A small, symptom-free nodule I would usually leave alone.
How do I lower the chance of lumps before I get injected?
Many Juvelook nodules are decided at the moment of injection: the depth, the dilution, whether the spread is even. When you book, it is worth asking which layer it will go into, how it is diluted, and why this material was chosen. Placed as a wide, superficial "skin booster," the odds of a gritty texture go up, and that is a conversation worth having before treatment, not after.
The bottom line
The reason a Juvelook lump is so unsettling is that "I dissolved it and it only half worked" is deeply counterintuitive. But once you lay out the logic, that it is a composite and only the HA half is soluble, the path forward has direction. Identify the material, triage the nodule, see it clearly on ultrasound, then observe what should be observed and remove what should be removed.
If you have a palpable lump or recurring redness after Juvelook or any "collagen needle," bring three facts to your online assessment and consultation: when you were injected, which product it was, and when the lump appeared and how it has changed. Those few sentences make the assessment far faster. You can also read the collagen stimulator nodule overview for the bigger picture.
References
- Magacho-Vieira FN, Ducati EPJ. Clinical Management of Poly-D,L-Lactic Acid Nodules: A Guideline With Diagnostic and Treatment Flowchart. J Cosmet Dermatol. 2025;24(4):e70158. PMID: 40162495. (Classification, onset timelines, and treatment flowchart for PDLLA nodules; cautions against overtreating minor asymptomatic nodules.)
- Seo SB, Wan J, Yi KH. Energy-Based Device Management of Nodular Reaction Following Poly-D,L-Lactic Acid Injection for Tear Trough Rejuvenation. J Cosmet Dermatol. 2025;24(1):e16575. PMID: 39283001. (Single case of a firm, non-inflammatory nodule about three weeks after Juvelook in the tear trough.)
- Perez Willis KM, Ramirez Galvez R. Granuloma after the Injection of Poly-D,L-Lactic Acid (PDLLA) Treated with Triamcinolone. Case Rep Dermatol Med. 2024;2024:6544506. (Granuloma four months after PDLLA, treated with intralesional triamcinolone, which outperformed collagenase; single case.)
- Seo SB, Park H, Jo JY, Ryu HJ. Skin rejuvenation effect of the combined PDLLA and non cross-linked hyaluronic acid: A preliminary study. J Cosmet Dermatol. 2024;23(3):794-802. PMID: 37969055. (Efficacy and dermal collagen/elastin increase for the PDLLA + non-cross-linked HA composite; preliminary study, n=16.)
- Lee KWA, Chan LKW, Lee AWK, et al. Poly-d,l-lactic Acid (PDLLA) Application in Dermatology: A Literature Review. Polymers (Basel). 2024;16(18):2583. PMID: 39339047. (PDLLA is amorphous, unlike crystalline PLLA; stimulates collagen via fibroblast and M2-macrophage pathways.)





